Replies to post #677481 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

And don’t forget the additional DCVax-l case report on an individual with a 50% inoperable tumor regressing accepted by a journal. Something is definitely up, imho.

[Survivor2012]

flipper44, do we know if these other countries (Israel, Japan, India, China, Australia, etc) have their own RAs that would require NWBO to submit "approval" requests/packages Also, wonder who, at NWBO is putting in all the hours on this, seemingly, proliferation of patent submssions and approvals? TIA

[Doc logic]

flipper44,

Linda has for years stated that L and Direct are essentially “the same” and only at different stages, mature vs immature and type of administration, intradermal vs intratumoral. Perhaps there will be compassionate use applications for D in the works soon after L approval. If so, about time some regulatory body recognizes the obvious. Best wishes.